WP
PRVL

Woodline Partners’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Woodline Partners’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-385,480
Closed -$3.92M – 292
2020
Q3 		$3.92M Buy
385,480
+56,345
+17% +$574K 0.13% 142
2020
Q2 		$4.9M Buy
329,135
+77,603
+31% +$1.16M 0.19% 115
2020
Q1 		$3.07M Buy
+251,532
New +$3.07M 0.22% 107